What is the significance of normal WBC, elevated RBC, high Hb, elevated Hct, normal MCV, MCH, and MCHC in a patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Your elevated red blood cell count, hemoglobin, and hematocrit levels do not necessitate therapeutic phlebotomy at this time, as they are below the threshold of hemoglobin greater than 20 g/dL and hematocrit greater than 65% recommended by the ACC/AHA guidelines 1. Your blood test results show that your white blood cell count is normal at 9.0 thousand/uL (reference range 3.8-10.8), indicating your immune system is functioning appropriately. However, your red blood cell count (5.46 million/uL), hemoglobin (16.2 g/dL), and hematocrit (48.5%) are all elevated above the normal ranges. These elevated values suggest a condition called erythrocytosis or polycythemia, which means you have an increased concentration of red blood cells in your blood. Some key points to consider:

  • Your red blood cell indices (MCV, MCH, MCHC) are normal, indicating the red blood cells themselves are of normal size and contain normal amounts of hemoglobin.
  • Elevated red blood cell parameters can sometimes indicate dehydration, living at high altitude, smoking, certain lung diseases, or potentially polycythemia vera (a bone marrow disorder) 1.
  • The ACC/AHA guidelines recommend therapeutic phlebotomy only when hemoglobin is greater than 20 g/dL and hematocrit is greater than 65% with associated symptoms of hyperviscosity and no evidence of dehydration 1. You should consult with your healthcare provider about these results, as they may recommend additional tests such as arterial oxygen saturation, serum erythropoietin level, or possibly bone marrow examination to determine the underlying cause. Staying well-hydrated before future blood tests may help if dehydration is contributing to these results.

From the Research

Blood Test Results

  • White blood cell count: 9.0 thousand/uL (normal range: 3.8-10.8 thousand/uL)
  • Red blood cell count: 5.46 million/uL (high, normal range: 3.80-5.10 million/uL)
  • Hemoglobin: 16.2 g/dL (high, normal range: 11.7-15.5 g/dL)
  • Hematocrit: 48.5 % (high, normal range: 35.0-45.0 %)
  • MCV: 88.8 fL (normal range: 80.0-100.0 fL)
  • MCH: 29.7 pg (normal range: 27.0-33.0 pg)
  • MCHC: 33.4

Possible Causes of High Red Blood Cell Count

  • Polycythemia vera (PV), a myeloproliferative neoplasm that is associated with an elevated risk of thrombosis 2, 3
  • Secondary polycythemias, caused by conditions resulting in increased EPO production 3
  • Chronic hypoxia, which can develop a physiologically appropriate "secondary" polycythemia that improves oxygen carrying capacity 4
  • Other non-hematological pathology, such as cardiopulmonary processes, drug-induced, or secondary to smoking 5

Diagnosis and Investigation

  • Measurement of the erythropoietin level is a first step to explore for a cause of erythrocytosis 6
  • A low erythropoietin level indicates a primary cause, and a normal or elevated level indicates a secondary etiology 6
  • Further investigation is then dictated by initial findings and includes mutational testing with PCR and NGS for those in whom a congenital cause is suspected 6
  • A systematic approach to the clinical and laboratory evaluation of each patient is indicated to consider diverse differential diagnosis possibilities and to identify the underlying etiology of erythrocytosis 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Iron deficiency and phlebotomy in patients with polycythemia vera.

International journal of hematology, 2025

Research

Why does my patient have erythrocytosis?

Hematology/oncology clinics of North America, 2012

Research

The clinical and laboratory evaluation of the patient with erythrocytosis.

European journal of internal medicine, 2015

Research

Erythrocytosis: Diagnosis and investigation.

International journal of laboratory hematology, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.